Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells

British Journal of Dermatology

Volumn 163, Issue 2, 2010, Pages 310-320

  Huang, S W ^a   Liu, K T ^b   Chang, C C ^a   Chen, Y J ^c   Wu, C Y ^c   Tsai, J J ^a,c   Lu, W C ^d   Wang, Y T ^d   Liu, C M ^d   Shieh, J J ^a,c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

apoptosis; autophagy; basal call carcinoma; imiquimod

Indexed keywords

BECLIN 1; CASPASE 3; IMIQUIMOD; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; AUTOPHAGY; BASAL CELL CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CARCINOMA, BASAL CELL; CASPASES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77954874814     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09827.x     Document Type: Article

References (37)

1. Lear JT, Harvey I, de Berker D et al. Basal cell carcinoma. J R Soc Med 1998 91 : 585 588.
2. Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994 5 : 367 392.
3. Stockfleth E, Meyer T, Benninghoff B et al. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001 144 : 1050 1053.
4. Tyring S, Conant M, Marini M et al. Imiquimod; an international update on therapeutic uses in dermatology. Int J Dermatol 2002 41 : 810 816.
5. Bong AB, Bonnekoh B, Franke I et al. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology 2002 205 : 135 138.
6. Schön MP, Wienrich BG, Drewniok C et al. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J Invest Dermatol 2004 122 : 1266 1276.
7. Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002 3 : 196 200.
8. Jurk M, Heil F, Vollmer J et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002 3 : 499.
9. Gorden KB, Gorski KS, Gibson SJ et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005 174 : 1259 1268.
10. Schön MP, Schön M, Klotz KN. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 2006 126 : 1338 1347.
11. Schön M, Bong AB, Drewniok C et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 2003 95 : 1138 1149.
12. Sidbury R, Neuschler N, Neuschler E et al. Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol 2003 121 : 1205 1209.
13. Smith EB, Schwartz M, Kawamoto H et al. Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. J Urol 2007 177 : 2347 2351.
14. Green DR. Apoptotic pathways: ten minutes to dead. Cell 2005 121 : 671 674.
15. Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008 9 : 378 390.
16. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev 2003 17 : 2481 2495.
17. Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003 3 : 17 22.
18. Mizushima N. Autophagy: process and function. Genes Dev 2007 21 : 2861 2873.
19. Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007 9 : 1102 1109.
20. Paglin S, Lee NY, Nakar C et al. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res 2005 65 : 11061 11070.
21. Kondo Y, Kanzawa T, Sawaya R et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005 5 : 726 734.
22. Delgado MA, Elmaoued RA, Davis AS et al. Toll-like receptors control autophagy. EMBO J 2008 27 : 1110 1121.
23. Xu Y, Jagannath C, Liu XD et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007 27 : 135 144.
24. Eisenberg-Lerner A, Bialik S, Simon HU et al. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009 16 : 966 975.
25. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest 2005 115 : 2679 2688.
26. Maiuri MC, Zalckvar E, Kimchi A et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007 8 : 741 752.
27. Yen HT, Chiang LC, Wen KH et al. The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch Dermatol Res 1996 288 : 157 161.
28. Klionsky DJ, Abeliovich H, Agostinis P et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008 4 : 151 175.
29. Yi JY, Jung YJ, Choi SS et al. Autophagy-mediated anti-tumoral activity of imiquimod in Caco-2 cells. Biochem Biophys Res Commun 2009 386 : 455 458.
30. Xue L, Fletcher GC, Tolkovsky AM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 1999 14 : 180 198.
31. Yokoyama T, Miyazawa K, Naito M et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy 2008 4 : 629 640.
32. Basciani S, Vona R, Matarrese P et al. Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells. FEBS Lett 2007 581 : 5897 5903.
33. Qian W, Liu J, Jin J et al. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk Res 2007 31 : 329 339.
34. Yang W, Monroe J, Zhang Y et al. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Cancer Lett 2006 243 : 217 227.
35. Yousefi S, Perozzo R, Schmid I et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006 8 : 1124 1132.
36. Yu L, Lenardo MJ, Baehrecke EH. Autophagy and caspases: a new cell death program. Cell Cycle 2004 3 : 1124 1126.
37. Vandenabeele P, Vanden Berghe T, Festjens N. Caspase inhibitors promote alternative cell death pathways. Sci STKE 2006 358 : pe 44.